Ziphius
- Biotech or pharma, therapeutic R&D
Presenting on Tuesday, June 17 at 3:30 PM in Room 153A.
Currently not seeking CRO, CDMO services.
Ziphius, a Belgium/US-based private biotech company, is advancing a next-generation platform utilizing self-amplifying RNA (saRNA) and lipid nanoparticles (LNPs) to develop first and best in class medicines for infectious diseases, rare diseases, and oncology.